News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Redmile Group, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/08/2023 |
SC 13G
| Redmile Group, LLC reports a 6.8% stake in AYALA PHARMACEUTICALS, Inc. |
| 10/17/2022 |
SC 13G
| Redmile Group, LLC reports a 10.1% stake in Zymeworks Inc. |
| 08/08/2022 |
SC 13G
| Redmile Group, LLC reports a 9.9% stake in Zymeworks Inc. |
| 06/03/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2022 |
SC 13G
| Redmile Group, LLC reports a 6.3% stake in Entrada Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| Redmile Group, LLC reports a 5.1% stake in Achilles Therapeutics plc |
| 06/07/2021 |
SC 13G
| Redmile Group, LLC reports a 8.5% stake in DYNAMICS SPECIAL PURPOSE CORP. |
| 04/08/2021 |
SC 13G
| Redmile Group, LLC reports a 11.1% stake in lAVA THERAPEUTICS N.V. |
| 02/16/2021 |
SC 13G
| Redmile Group, LLC reports a 7.2% stake in Repare therapeutics Inc. |
| 02/16/2021 |
SC 13G
| Redmile Group, LLC reports a 5% stake in Itamar medical ltd. |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Redmile Group, LLC reports a 9.9% stake in Neoleukin therapeutics, inc. |
| 02/16/2021 |
SC 13G
| Redmile Group, LLC reports a 6.1% stake in Kymera Therapeutics, INC. |
| 02/16/2021 |
SC 13G
| Redmile Group, LLC reports a 6% stake in Zentalis Pharmaceuticals, INC. |
| 02/16/2021 |
SC 13G
| Redmile Group, LLC reports a 6.6% stake in Yumanity Therapeutics, Inc. |
| 02/16/2021 |
SC 13G
| Redmile Group, LLC reports a 7.4% stake in Stoke therapeutics, Inc. |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Redmile Group, LLC reports a 5.7% stake in Cabaletta BIO, Inc. |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Redmile Group, LLC reports a 5.2% stake in AYALA PHARMACEUTICALS, Inc. |
| 02/16/2021 |
SC 13G
| Redmile Group, LLC reports a 7.9% stake in Avita Medical, Inc. |
| 02/16/2021 |
SC 13G
| Redmile Group, LLC reports a 9% stake in ANNEXON, Inc. |
| 02/16/2021 |
SC 13G
| Redmile Group, LLC reports a 6.7% stake in Akero Therapeutics, Inc. |
| 02/16/2021 |
SC 13G
| Redmile Group, LLC reports a 8.8% stake in ADC Therapeutics SA |
| 06/09/2020 |
SC 13G
| Redmile Group, LLC reports a 9.6% stake in PLIANT THERAPEUTICS, Inc. |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| Redmile Group, LLC reports a 6.2% stake in Allakos Inc. |
| 02/14/2020 |
SC 13G
| Redmile Group, LLC reports a 9.2% stake in Deciphera Pharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G
| Redmile Group, LLC reports a 6.3% stake in Krystal Biotech, Inc. |
| 02/14/2020 |
SC 13G
| Redmile Group, LLC reports a 8.3% stake in Principia Biopharma Inc. |
|
|
|